On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

National Cheng Kung University Hospital

InstitutionResearch output, impact & collaborations

National Cheng Kung University Hospital is a institution indexed in ScholarIQ from OpenAlex.

What is known about National Cheng Kung University Hospital?

ScholarIQrecord summary

National Cheng Kung University Hospital is a research organisation in Tainan City, TW. OpenAlex records 14,905 works and 741,178 citations for it. 4,540 researchers list it as their most recent affiliation.

How many works does National Cheng Kung University Hospital have?

ScholarIQindexed works

National Cheng Kung University Hospital has 14,905 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for National Cheng Kung University Hospital →

How many citations does National Cheng Kung University Hospital have?

ScholarIQcitation count

National Cheng Kung University Hospital has 741,178 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for National Cheng Kung University Hospital →

How many researchers are at National Cheng Kung University Hospital?

ScholarIQresearcher count

National Cheng Kung University Hospital has 4,540 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at National Cheng Kung University Hospital?

ScholarIQavg h-index

National Cheng Kung University Hospital has an average h-index of 43.3 in OpenAlex.

Open the OpenAlex record →

What is the ROR of National Cheng Kung University Hospital?

ScholarIQror

The ROR for National Cheng Kung University Hospital is on the source record.

Open the ROR →

What is the OpenAlex record for National Cheng Kung University Hospital?

ScholarIQopenalex

The OpenAlex for National Cheng Kung University Hospital is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind National Cheng Kung University Hospital?

ScholarIQtop researchers by citations

Wu‐Chou Su · Lung Cancer Treatments and Mutations

660 works38,133 citations

Wen‐Chien Ko · Antibiotic Resistance in Bacteria

815 works33,783 citations

Jung‐Der Wang · Health Systems, Economic Evaluations, Quality of Life

475 works13,100 citations

Chaw‐Ning Lee · Psoriasis: Treatment and Pathogenesis

56 works927 citations

Ching‐Ju Fang · Sleep and related disorders

47 works903 citations

What are the most-cited papers on National Cheng Kung University Hospital?

ScholarIQmost cited works

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

Chih‐Cheng Lai, Tzu-Ping Shih, Wen‐Chien Ko, Hung-Jen Tang, Po‐Ren Hsueh

International Journal of Antimicrobial Agents. 20206,389 CitationsOPEN ACCESS

Osimertinib in Untreated <i>EGFR</i> -Mutated Advanced Non–Small-Cell Lung Cancer

Jean‐Charles Soria, Yuichiro Ohe, Johan Vansteenkiste, Thanyanan Reungwetwattana, Busyamas Chewaskulyong, Ki Hyeong Lee, Arunee Dechaphunkul, Fumio Imamura, Naoyuki Nogami, Takayasu Kurata, Isamu Okamoto, Caicun Zhou, Byoung Chul Cho, Ying Cheng, Eun Kyung Cho, Pei Jye Voon, David Planchard, Wu‐Chou Su, Jhanelle E. Gray, Siow Ming Lee, Rachel Hodge, Marcelo Marotti, Yuri Rukazenkov, Suresh S. Ramalingam

New England Journal of Medicine. 20175,376 CitationsOPEN ACCESS

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations

Lecia V. Sequist, James Chih‐Hsin Yang, Nobuyuki Yamamoto, Kenneth J. O’Byrne, Vera Hirsh, Tony Mok, Sarayut Lucien Geater, С. В. Орлов, Chun‐Ming Tsai, Michael Boyer, Wu‐Chou Su, Jaafar Bennouna, Terufumi Kato, В. А. Горбунова, Ki Hyeong Lee, Riyaz Shah, Dan Massey, Victoria Zazulina, Mehdi Shahidi, Martin Schüler

Journal of Clinical Oncology. 20133,210 Citations

AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer

Pasi A. Jänne, James Chih‐Hsin Yang, Dong‐Wan Kim, David Planchard, Yuichiro Ohe, Suresh S. Ramalingam, Myung‐Ju Ahn, Sang-We Kim, Wu‐Chou Su, Leora Horn, Daniel Haggstrom, Enriqueta Felip, Joo-Hang Kim, Paul Frewer, Mireille Cantarini, Kathryn H. Brown, Paul A. Dickinson, Serban Ghiorghiu, Malcolm Ranson

New England Journal of Medicine. 20152,126 CitationsOPEN ACCESS

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

James Chih‐Hsin Yang, Yi‐Long Wu, Martin Schüler, Martin Sebastian, Sanjay Popat, Nobuyuki Yamamoto, Caicun Zhou, Cheng-Ping Hu, Kenneth J. O’Byrne, Jifeng Feng, Shun Lü, Yunchao Huang, Sarayut Lucien Geater, Kye Young Lee, Chun-Ming Tsai, В. А. Горбунова, Vera Hirsh, Jaafar Bennouna, С. В. Орлов, Tony Mok, Michael Boyer, Wu‐Chou Su, Ki Hyeong Lee, Terufumi Kato, Dan Massey, Mehdi Shahidi, Victoria Zazulina, Lecia V. Sequist

The Lancet Oncology. 20151,585 Citations

How much of the research on National Cheng Kung University Hospital is open access?

ScholarIQopen access share

58%OPEN ACCESS

Gold

17%

Green

17%

Hybrid

Bronze

25%

Closed

42%